In a report released today, Alec Stranahan from Bank of America Securities maintained a Buy rating on Sana Biotechnology (SANA – Research ...

On Tuesday, Sana Biotechnology Inc (SANA) stock saw a decline, ending the day at $3.39 which represents a decrease of $-0.37 or -9.84% from the prior close of $3.76. The stock opened at $3.5 and ...

Thryv Therapeutics Inc., a clinical-stage biotechnology company pioneering novel therapies for cardiovascular diseases, is ...

An in-depth analysis in the United States, covering 2002 to 2023, reveals that biological contamination and allergens are the leading causes of food recalls. The study, recently published in the ...